Search results
Results from the WOW.Com Content Network
Shine Technologies (stylized as SHINE Technologies) is a private corporation based in Janesville, Wisconsin.The company applies nuclear fusion and advanced separation technologies across fields of critical need, including nondestructive testing, radiation hardening services for industrial and defense applications, and the production of radioisotopes, including n.c.a. lutetium-177 for cancer ...
317 covered all of Northern and Central Indiana until 1948, when 219 was created. Central Indiana remained under the 317 banner until 1997, when growth in and around Indianapolis prompted the creation of 765. The 317 area code was, in turn, overlaid by 463 in 2016.
GE Healthcare Technologies, Inc. is an American health technology company based in Chicago, Illinois.The company, which stylizes its own name as GE HealthCare, operates four divisions: Medical imaging, which includes molecular imaging, computed tomography, magnetic resonance, women’s health screening and X-ray systems; Ultrasound; Patient Care Solutions, which is focused on remote patient ...
In nuclear medicine imaging, radiopharmaceuticals are taken internally, for example, through inhalation, intravenously, or orally. Then, external detectors (gamma cameras) capture and form images from the radiation emitted by the radiopharmaceuticals. This process is unlike a diagnostic X-ray, where external radiation is passed through the body ...
The concept of nuclear pharmacy was first described in 1960 by Captain William H. Briner while at the National Institutes of Health (NIH) in Bethesda, Maryland.Along with Mr. Briner, John E. Christian, who was a professor in the School of Pharmacy at Purdue University, had written articles and contributed in other ways to set the stage of nuclear pharmacy.
Nuclear medicine physicians, also called nuclear radiologists or simply nucleologists, [1] [2] are medical specialists that use tracers, usually radiopharmaceuticals, for diagnosis and therapy. Nuclear medicine procedures are the major clinical applications of molecular imaging and molecular therapy.
Despite Indianapolis's rapid growth during the second half of the 20th century, and the accompanying increased number demand, this configuration remained in place for 48 years. No changes were made to 317 until February 1, 1997, when most of the old 317 territory outside of the inner ring of the Indianapolis metropolitan area switched to 765. [2]
[6] [7] In 2013, Indiana governor Mike Pence announced the formation of the IBRI. [8] Pence later worked with life sciences leaders to secure $25 million in startup funds from the state. [9] In 2015, the IBRI hired David Broecker as CEO. [10] In late 2015, the Indianapolis City-County Council approved $75 million to build a technology park ...